Clinical and Cognitive Effects of Paliperidone Palmitate vs. Oral Risperidone in First-Episode Schizophrenia

Trial Profile

Clinical and Cognitive Effects of Paliperidone Palmitate vs. Oral Risperidone in First-Episode Schizophrenia

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2018

At a glance

  • Drugs Paliperidone (Primary) ; Risperidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2020.
    • 18 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2020.
    • 10 Jun 2013 Planned number of patients changed from 150 to 170 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top